J Borras Blasco

Summary

Affiliation: Servicio de Farmacia
Country: Spain

Publications

  1. ncbi Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature
    J Borras-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Int J Clin Pharmacol Ther 41:213-6. 2003
  2. ncbi Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient
    Joaquín Borrás-Blasco
    Pharmacy Service, The Gastroenterology Section, Hospital de Sagunto, Valencia, Spain
    South Med J 101:88-90. 2008
  3. ncbi Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    J Clin Pharm Ther 32:651-4. 2007
  4. ncbi Hair loss induced by lopinavir-ritonavir
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Valencia, Spain
    Pharmacotherapy 27:1215-8. 2007
  5. ncbi Unrecognized delayed toxic lithium peak concentration in an acute poisoning with sustained release lithium product
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Avda Ramon y Cajal s n, Sagunto 46520, Valencia, Spain
    South Med J 100:321-3. 2007
  6. ncbi Parapharyngeal abscess in a patient receiving etanercept
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    Ann Pharmacother 41:341-4. 2007
  7. ncbi Possible macular exanthema associated with linezolid therapy
    J Borras-Blasco
    Hospital Pharmacy, Pharmacy Service, Hospital de Sagunto, Valencia, Spain
    Int J Clin Pharmacol Ther 44:331-4. 2006
  8. ncbi Acute renal failure associated with an accidental overdose of colchicine
    J Borras-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Spain
    Int J Clin Pharmacol Ther 43:480-4. 2005
  9. ncbi [Acute intoxication with sustained-release lithium carbonate tablets. A propos of a case]
    J Borras Blasco
    Servicio de Farmacia, Seccion de Nefrologia, Hospital General Universitario, Elche, Alicante
    Farm Hosp 29:140-3. 2005
  10. ncbi [Headache associated with cyclosporin ina patient with membranous glomerulonephritis]
    J Borras Blasco
    Servicio de Farmacia, Hospital General Universitario de Elche, Alicante
    Farm Hosp 28:454-7. 2004

Collaborators

  • Joaquín Borrás-Blasco
  • A Navarro Ruiz
  • J Fernandez
  • A Murcia López
  • D Rosique Robles
  • R Antón Torres
  • M Gonzalez Delgado
  • D Rosique-Robles
  • V Giner Marco
  • J Abad
  • V Giner-Marco
  • J M Vicent Verge
  • E Casterá
  • A Galan Brotons
  • A Galan-Brotons
  • J F Navarro Gracia
  • J J Martínez Toldos
  • M C Alvarado Valero

Detail Information

Publications18

  1. ncbi Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature
    J Borras-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Int J Clin Pharmacol Ther 41:213-6. 2003
    ..To report a case of Henoch-Schönlein purpura that appears to be related to the intake of clarithromycin for pharyngitis/tonsillitis...
  2. ncbi Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient
    Joaquín Borrás-Blasco
    Pharmacy Service, The Gastroenterology Section, Hospital de Sagunto, Valencia, Spain
    South Med J 101:88-90. 2008
    ..To report a case of severe stomatitis probably induced by peginterferon alpha-2a...
  3. ncbi Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    J Clin Pharm Ther 32:651-4. 2007
    ..To report a case of possible delayed-onset osteonecrosis of the jaw after treatment with zoledronic acid...
  4. ncbi Hair loss induced by lopinavir-ritonavir
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Valencia, Spain
    Pharmacotherapy 27:1215-8. 2007
    ..If alopecia is severe or particularly distressing to the patient, the offending drug should be discontinued, and therapy with another HIV drug should be started...
  5. ncbi Unrecognized delayed toxic lithium peak concentration in an acute poisoning with sustained release lithium product
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Avda Ramon y Cajal s n, Sagunto 46520, Valencia, Spain
    South Med J 100:321-3. 2007
    ..Therefore, patients presenting with acute intoxication with extended release formulations should be managed with caution, and continued drug monitoring is suggested...
  6. ncbi Parapharyngeal abscess in a patient receiving etanercept
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    Ann Pharmacother 41:341-4. 2007
    ..To report a case of parapharyngeal abscess associated with Streptococcus viridans in a patient with rheumatoid arthritis receiving treatment with etanercept...
  7. ncbi Possible macular exanthema associated with linezolid therapy
    J Borras-Blasco
    Hospital Pharmacy, Pharmacy Service, Hospital de Sagunto, Valencia, Spain
    Int J Clin Pharmacol Ther 44:331-4. 2006
    ..To report a case of macular exanthema associated with linezolid therapy...
  8. ncbi Acute renal failure associated with an accidental overdose of colchicine
    J Borras-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Spain
    Int J Clin Pharmacol Ther 43:480-4. 2005
    ..Some colchicine intoxications, as in this case, are caused by an error in interpreting the dose for treating an acute attack of gout. A way to prevent these errors would be to use a low-dose treatment protocol...
  9. ncbi [Acute intoxication with sustained-release lithium carbonate tablets. A propos of a case]
    J Borras Blasco
    Servicio de Farmacia, Seccion de Nefrologia, Hospital General Universitario, Elche, Alicante
    Farm Hosp 29:140-3. 2005
    ..To describe the case of a patient who ingested 50 sustained release lithium carbonate 400 mg tablets, and reached a late peak concentration above 3 mEq/L...
  10. ncbi [Headache associated with cyclosporin ina patient with membranous glomerulonephritis]
    J Borras Blasco
    Servicio de Farmacia, Hospital General Universitario de Elche, Alicante
    Farm Hosp 28:454-7. 2004
    ..To report the case of a patient diagnosed with membranous glomerulonephritis and autoimmune non-central neutropenia under treatment with cyclosporin who developed severe, disabling headache...
  11. ncbi Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Ann Pharmacother 37:1241-3. 2003
    ..To report a case of photo-induced Stevens-Johnson Syndrome (SJS) due to sulfasalazine therapy...
  12. ncbi Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin
    D Rosique Robles
    Hospital Pharmacy, Pharmacy Service, Hospital de Sagunto, Spain
    Int J Clin Pharmacol Ther 45:606-10. 2007
    ..To report the successful desensitization of a patient with a hypersensitivity reaction to oxaliplatin...
  13. ncbi Acenocoumarol-induced Henoch-Schönlein purpura
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Ann Pharmacother 38:261-4. 2004
    ..To report a probable case of Henoch-Schönlein purpura associated with acenocoumarol therapy...
  14. ncbi [Drug therapy for corneo-conjunctival neoplasm]
    A Murcia López
    Servicio de Oftalmologia, Hospital General Universitario de Elche, Alicante, Spain
    Farm Hosp 29:126-33. 2005
    ..The administration of a number of topically administered drugs has been used for adjuvant therapy, including mitomycin C, 5-fluorouracil and interferon a 2b...
  15. ncbi Adverse cutaneous reactions induced by TNF-alpha antagonist therapy
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:1133-40. 2009
    ..To review adverse cutaneous drug reactions induced by tumor necrosis factor alpha (TNF-alpha) antagonist therapy...
  16. ncbi [Assessment of quality as perceived by users of an outpatient pharmaceutical care unit]
    R Antón Torres
    Servicios de Farmacia y Medicina Preventiva Hospital General Universitario, Alicante, Spain
    Farm Hosp 30:99-104. 2006
    ..To assess quality of care by an Outpatient Pharmaceutical Care Unit (OPCU) from patient satisfaction regarding the unit s premises and activities...
  17. ncbi Urticaria due to etanercept in a patient with psoriatic arthritis
    Joaquín Borrás-Blasco
    Pharmacy Service and Rehabilitation Section, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:304-5. 2009
    ..The adverse reaction could be considered probable. Although the overall risk of skin adverse events associated with etanercept appears low, clinicians should be aware of this reaction...
  18. ncbi Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen
    Joaquín Borrás-Blasco
    Hospital de Sagunto, Pharmacy Department, Avda Ramon y Cajal s n, Sagunto, Valencia, Spain
    Expert Opin Biol Ther 10:301-7. 2010
    ..To assess patients' acceptance of switching adalimumab from a prefilled syringe to an autoinjection pen...